KMDA

Kamada Ltd

• TipRanks·4d ago

  Benchmark Co. Sticks to Their Buy Rating for Kamada (KMDA)

• TipRanks·5d ago

  Kamada Signs Three-Year, $50 Million Plasma Supply Deal to Bolster Growth

• TipRanks·5d ago

  Kamada enters $50M sales agreement to supply plasma to biopharmaceutical company

• Benzinga·5d ago

  Kamada Signs $50M Plasma Supply Agreement With Biopharma Partner Through Texas Centers, Commercial Sales Starting Q4 2026

• TipRanks·07/13 17:20

  Kamada Showcases New CYTOGAM Data from 2026 ISHLT Meeting, Signaling Potential Uptick in Transplant Use

• TipRanks·07/13 11:20

  Kamada highlights Cytogam study results

• Benzinga·07/13 11:19

  Kamada Highlights Results Of An Investigator-initiated Study Of Cytogam, The Company’s Cytomegalovirus Immune Globulin, In The Management Of Cytomegalovirus In Solid Organ Transplantation

• TipRanks·06/18 11:35

  Kamada Sets August 5, 2026 Annual General Meeting to Vote on Board, Option Plan and Auditor

• Seeking Alpha·06/02 18:11

  Kamada: Undervalued, Yet Execution Risks Keep It A Hold

• NASDAQ·06/01 12:37

  Kamada Receives FDA Approval For In-House Rabies Virus Neutralization Testing Laboratory

• TipRanks·06/01 11:59

  Kamada gets FDA approval for Rapid Fluorescent Focus Inhibition Test laboratory

• TipRanks·06/01 11:31

  Kamada Wins FDA Nod for New In‑House Rabies Antibody Testing Lab

• Benzinga·06/01 11:05

  Kamada Announces FDA Approval Of New In-House Rapid Fluorescent Focus Inhibition Test Laboratory

• TipRanks·05/20 04:30

  Kamada Ltd Earnings Call Balances Growth And Risks

• TipRanks·05/14 10:35

  Kamada (KMDA) Gets a Buy from H.C. Wainwright